Answers are grounded in this paper and cite their sources.
Clinical practice guideline reports comprehensive management pathways for pediatric aggressive mature B-cell lymphomas, highlighting standardized protocols for curable disease.
Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: